Ignava 25000IU Injection
Marketer
Health Biotech Limited
Salt Composition
Heparin (25000IU)
Overview Ignava 25000IU Injection
Heparin 25000IU Injection acts as a blood thinner, preventing the development of potentially dangerous blood clots. This medication inhibits clot formation and growth in vital areas such as the legs, lungs, and heart. Administration of Heparin 25000IU Injection requires strict medical oversight; your physician will determine the appropriate dosage frequency, which may be adjusted based on treatment efficacy. Consistent use is crucial for optimal preventative benefits, regardless of feeling well. Regular blood tests will monitor treatment effectiveness and assess potassium and platelet levels. Increased bleeding risk is a potential side effect. Report any signs of internal bleeding, such as pinpoint rashes or blood in bodily fluids (vomit, urine, or stool), immediately to your doctor. Exercise caution with activities that may cause injury, including shaving, nail trimming, use of sharp instruments, and contact sports. Prior to commencing treatment, disclose all existing health conditions and medications to your physician. Pregnant patients should seek medical advice regarding the safety of this medication.
Uses of Ignava 25000IU Injection
Thrombosis prophylaxis
Major Benefits of Ignava 25000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ignava 25000IU Injection:
- Bleeding
- Erythema (skin redness)
How to use Ignava 25000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ignava 25000IU Injection works:
Heparin Sodium 25000IU Injection acts as a blood thinner, inhibiting the development of potentially dangerous blood clots. While it lacks the ability to break down pre-existing clots, it effectively prevents further clot growth and subsequent vessel obstructions.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Ignava 25000IU Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Ignava 25000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, Ignava 25000IU Injection presents a low safety risk. Research in humans indicates minimal drug transfer into breast milk, posing no apparent threat to the infant. The negligible quantities of Ignava 25000IU Injection detected in breast milk result in insignificant infant exposure, precluding harmful consequences.
DrivingSAFE
Driving ability is typically unaffected by Ignava 25000IU Injection.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Ignava 25000IU Injection is considered safe and does not require a dosage modification. Nevertheless, disclosure of any pre-existing kidney conditions to your physician is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Ignava 25000IU Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Ignava 25000IU Injection :
Should you forget a dose of Ignava 25000IU Injection, seek your physician's advice.
Facts to Know About Ignava 25000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Glycosaminoglycan Sulfate |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Unfractionated Heparin |
3,018 People bought this recently